What is TVGNW's market cap?

$1.08M, based on the Sep 28 close of $0.06.

What sector is TVGNW in?

Healthcare, in the Biotechnology industry.

NASDAQ · TVGNWHealthcareBiotechnology

Tevogen Inc. Warrant (TVGNW)

$0.0601−7.54%

Close Sep 28, 2026 · split-adjusted

Sep 28, 2026$0.06▲ 9.27% in range

Sep 29, 2025Low $0.03 · High $0.07Sep 28, 2026

What changed · written from our data

As of Sep 28, 2026

Tevogen Inc. Warrant closed at $0.06 on Sep 28, down 7.54%, 7.5% below its highest close since Feb 15. Volume of 306.4K shares was 0.69× its 20-day average (below normal).

Split-adjusted performance: +15.1% over one month, +84.4% over six months.

Short interest was 86.3K shares at the Sep 15 settlement, up 6.2% from the prior report (1.0 days to cover).

Market cap$1.1M18.0M shares

Revenue · quarter$0.00—

Diluted EPS$-1.52—

P/E · TTM—

Net margin—

Dividend yieldNone

Range since Feb 150.03 – 0.07−7.5% from high

Volume306.4K0.69× 20-day avg

Volatility · 60d94.8%Annualised

Short % of float—1.0 days to cover

Net cash-$7.0MCash $1.1M

Next earnings—Not scheduled

Split-adjusted performance

1W +9.3%1M +15.1%3M +5.8%6M +84.4%YTD +42.4%1Y —3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Biotechnology

Percentile among 139 companies (100 = best)

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Industry medians: 6-month return −3.9%, revenue growth +9.0%, net margin −231.7%, P/E 20.2×.

Short interest

Details →

Shares short86.3K+6.2% vs prior

Days to cover1.0Settled Sep 15

% of float—

Short vol. 10d18.5%of daily volume

Closest peers by size in Biotechnology

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
TVGNWTevogen Inc. Warrant	$0.0601	−7.54%	+84.4%	—	—	—	$1.1M
ESLAWEstrella Immunopharma, Inc. Warrant	$0.0600	−14.29%	—	—	—	—	$132.9K	Compare
RVMDWRevolution Medicines, Inc. Warrant	$11.22	−3.48%	+586.2%	—	—	—	$123.9M	Compare

News about Tevogen Inc. Warrant

All news →

Tevogen Bio Announces 2026 Annual Meeting of StockholdersGlobeNewswire Inc. · Jul 14, 2026Neutral Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services OrganizationBenzinga · May 21, 2026▲ Positive Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share UtilizationGlobeNewswire Inc. · Mar 13, 2026▲ Positive Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care PlatformGlobeNewswire Inc. · Mar 11, 2026▲ Positive Tevogen Bio Explores Buyout To Boost Generics PlatformBenzinga · Mar 6, 2026▼ Negative

Quick answers

What does Tevogen Inc. Warrant do?: Tevogen Inc is a healthcare enterprise engaged in biotechnology, artificial intelligence and technology, and healthcare services. Its operations focus on the development of biotechnology products, AI- and technology-based healthcare solutions, and healthcare service initiatives.
What is TVGNW's market cap?: $1.08M, based on the Sep 28 close of $0.06.
What sector is TVGNW in?: Healthcare, in the Biotechnology industry.

About Tevogen Inc. Warrant

Tevogen Inc is a healthcare enterprise engaged in biotechnology, artificial intelligence and technology, and healthcare services. Its operations focus on the development of biotechnology products, AI- and technology-based healthcare solutions, and healthcare service initiatives.

HQ: Warren, NJ18 employeesListed Feb 15, 2024tevogen.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology